Synthesis and pharmacological evaluation of (2-oxaadamant-1-yl)amines

Bioorganic and Medicinal Chemistry

Volumn 17, Issue 8, 2009, Pages 3198-3206

  Duque, María D ^a   Camps, Pelayo ^a   Profire, Lenuta ^a   Montaner, Silvia ^a   Vázquez, Santiago ^a   Sureda, Francesc X ^b   Mallol, Jordi ^b   López Querol, Marta ^b   Naesens, Lieve ^c   Clercq, Erik De ^c   Radhika Prathalingam, S ^d   Kelly, John M ^d  

^a UNIVERSITY OF BARCELONA   (Spain)

^b FACULTAT DE MEDICINA I CIÈNCIES DE LA SALUT   (Spain)

^c REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Adamantane; Amantadine; Cage compounds; Memantine; NGP1 01; NMDA; Trypanosoma

Indexed keywords

(2 OXAADAMANT 1 YL)AMINE; (2 OXAADAMANT 1 YL)AMINE DERIVATIVE; (3 CYCLOHEXYL 2 OXAADAMANT 1 YL)AMINE; (3 ETHYL 2 OXAADAMANT 1 YL)AMINE; (3 ETHYL 2 OXAADAMANT 1 YL)HYDRAZINE; (3 METHYL 2 OXAADAMANT 1 YL)AMINE; (3 METHYL 2 OXAADAMANT 1 YL)HYDRAZINE; (3 PHENYL 2 OXAADAMANT 1 YL)AMINE; (3 PHENYL 2 OXAADAMANT 1 YL)HYDRAZINE; AMANTADINE; AMANTADINE DERIVATIVE; MEMANTINE; N (2 PHENYLETHYL)(2 OXAADAMANT 1 YL)AMINE; N BENZYL N METHYL(2 OXAADAMANT 1 YL)AMINE; N BENZYL N METHYL(3 ETHYL 2 OXAADAMANT 1 YL)AMINE; N BENZYL(2 OXAADAMANT 1 YL)AMINE; N BENZYL(3 ETHYL 2 OXAADAMANT 1 YL)AMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; N METHYL N (2 PHENYLETHYL)(2 OXAADAMANT 1 YL)AMINE; N METHYL(2 OXAADAMANT 1 YL)AMINE; N METHYL(3 ETHYL 2 OXAADAMANT 1 YL)AMINE; N,N DIBENZYL(2 OXAADAMANT 1 YL)AMINE; N,N DIETHYL(3 ETHYL 2 OXAADAMANT 1 YL)AMINE; N,N DIMETHYL(3 ETHYL 2 OXAADAMANT 1 YL)AMINE; N,N DIMETHYL(3 METHYL 2 OXAADAMANT 1 YL)AMINE; NGP1 01; RIMANTADINE; UNCLASSIFIED DRUG;

ANTIPROTOZOAL ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG STRUCTURE; DRUG SYNTHESIS; NONHUMAN; STRUCTURE ANALYSIS;

TRYPANOSOMA;

EID: 64049100364     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2009.02.007     Document Type: Article

References (44)

1. Danysz W., Parsons C.G., Kornhuber J., Schmidt W.J., and Quack G. Neurosci. Biobehav. Rev. 21 (1997) 455
2. Palmer G.C. Curr. Drug Targets 2 (2001) 241
3. Aoki F. In: Nicholson K.G., Webster R.G., and Hay A.J. (Eds). Textbook of Influenza (1998), Blackwell Science, Oxford 457-476
4. De Clercq E. Nat. Rev. Drug Disc. 5 (2006) 1015
5. Geluk H.W., Schut J., and Schlatmann J.L.M.A. J. Med. Chem. 12 (1969) 712
6. Aldrich P.E., Hermann E.C., Meier W.E., Paulshock M., Prichard W.W., Snyder J.A., and Watts J.C. J. Med. Chem. 14 (1971) 535
7. Tilley T.W., Levitan P., and Kramer M.J. J. Med. Chem. 22 (1979) 1009
8. Kolocouris N., Foscolos G.B., Kolocouris A., Marakos P., Pouli N., Fytas G., Ikeda S., and De Clercq E. J. Med. Chem. 37 (1994) 2896
9. Kolocouris N., Kolocouris A., Foscolos G.B., Fytas G., Neyts J., Padalko E., Balzarini J., Snoeck R., Andrei G., and De Clercq E. J. Med. Chem. 39 (1996) 3307
10. Van Derpoorten K., Balzarini J., De Clercq E., and Poupaert J.H. Biomed. Pharmacother. 51 (1997) 464
11. Scholtissek C., Quack G., Klenk H.D., and Webster R.G. Antiviral Res. 37 (1998) 83
12. Burstein M.E., Serbin A.V., Khakhulina T.V., Alymova I.V., Stotskaya L.L., Bogdan O.P., Manukchina E.E., Jdanov V.V., and Sharova N.K. Antiviral Res. 41 (1999) 135
13. Stamatiou G., Kolocouris A., Kolocouris N., Fytas G., Foscolos G.B., Neyts J., and De Clercq E. Bioorg. Med. Chem. Lett. 11 (2001) 2137
14. Zoidis G., Kolocouris N., Foscolos G.B., Kolocouris A., Fytas G., Karayannis P., Padalko E., Neyts J., and De Clercq E. Antiviral Chem. Chemother. 14 (2003) 153
15. Stylianakis I., Kolocouris A., Kolocouris N., Fytas G., Foscolos G.B., Padalko E., Neyts J., and De Clercq E. Bioorg. Med. Chem. Lett. 13 (2003) 1699
16. Stamatiou G., Foscolos G.B., Fytas G., Kolocouris A., Kolocouris N., Pannecouque C., Wytvrouw M., Padalko E., Neyts J., and De Clercq E. Bioorg. Med. Chem. 11 (2003) 5485
17. El-Emam A.A., Al-Deeb O.A., Al-Omar M., and Lehmann J. Bioorg. Med. Chem. 12 (2004) 5107
18. Zoidis G., Fytas C., Papanastasiou I., Foscolos G.B., Fytas G., Padalko E., De Clercq E., Naesens L., Neyts J., and Kolocouris N. Bioorg. Med. Chem. 14 (2006) 3341
19. Setaki D., Tataridis D., Stamatiou G., Kolocouris N., Foscolos G.B., Fytas G., Kolocouris N., Padalko E., Neyts J., and De Clercq E. Bioorg. Chem. 34 (2006) 248;
20. Tataridis D., Fytas G., Kolocouris N., Fytas C., Kolocouris N., Foscolos G.B., Padalko E., Neyts J., and De Clercq E. Bioorg. Med. Chem. Lett. 17 (2007) 692
21. Kelly J.M., Miles M.A., and Skinner A.C. Antimicrob. Agents Chemother. 43 (1999) 985
22. Kelly J.M., Quack G., and Miles M.A. Antimicrob. Agents Chemother. 45 (2001) 1360
23. Kolocouris N., Zoidis G., Foscolos G.B., Fytas G., Prathalingam S.R., Kelly J.M., Naesens L., and De Clercq E. Bioorg. Med. Chem. Lett. 17 (2007) 4358
24. Papanastasiou I., Tsotinis A., Kolocouris N., Prathalingam S.R., and Kelly J.M. J. Med. Chem. 51 (2008) 1496
25. Patrick G.L. An Introduction to Medicinal Chemistry (2005), Oxford University Press, Oxford pp 204-205
26. Geldenhuys W.J., Malan S.F., Bloomquist J.R., Marchand A.P., and van der Schyf C.J. Med. Res. Rev. 25 (2005) 21
27. Mdzinarishvili A., Geldenhuys W.J., Abbruscato T.J., Bickel U., Klein J., and van der Schyf C.J. Neurosci. Lett. 383 (2005) 49
28. Grobler E., Grobler A., van der Schyf C.J., and Malan S.F. Bioorg. Med. Chem. 14 (2006) 1176
29. Kiewert C., Hartmann J., Stoll J., Thekkumkara T.J., Geldenhuys W.J., and Klein J. Neurochem. Res. 31 (2006) 395
30. Geldenhuys W.J., Malan S.F., Bloomquist J.R., and van der Schyf C.J. Bioorg. Med. Chem. 15 (2007) 1525
31. Hao J., Mdzinarishvili A., Abbruscato T.J., Klein J., Geldenhuys W.J., van der Schyf C.J., and Bickel U. Brain Res. 1196 (2008) 113
32. Stetter H., and Tacke P. Chem. Ber. 96 (1963) 694
33. Bertz S.H. J. Org. Chem. 50 (1985) 3585
34. Geigy A. G. Patent GB 1123609, 1968.
35. Gagneux A.R., and Meier R. Tetrahedron Lett. (1969) 1365
36. Stetter H., Gaertner J., and Tacke P. Chem. Ber. 99 (1966) 1435
37. Camps P., El Achab R., Font-Bardia M., Görbig D.M., Morral J., Muñoz-Torrero D., Solans X., and Simon M. Tetrahedron 52 (1996) 5867
38. Camps P., El Achab R., Görbig D.M., Morral J., Muñoz-Torrero D., Badia A., Baños J.E., Vivas N.M., Barril X., Orozco M., and Luque F.J. J. Med. Chem. 42 (1999) 3227
39. Robinson D.M., and Keating G.M. Drugs 66 (2006) 1515
40. Canudas A.M., Pubill D., Sureda F.X., Verdaguer E., Camps P., Muñoz-Torrero D., Jiménez A., Camins A., and Pallàs M. Exp. Neurol. 180 (2003) 123
41. Camps P., Duque M.D., Vázquez S., Naesens L., De Clercq E., Sureda F.S., López-Querol M., Camins A., Pallàs M., Prathalingam S.R., Kelly J.M., Romero V., Ivorra D., and Cortés D. Bioorg. Med. Chem. 16 (2008) 9925
42. De Clercq E., Cools M., Balzarini J., Márquez V.E., Borcherding D.R., Borchardt R.T., Drach J.C., Kitaoka S., and Konno T. Antimicrob. Agents Chemother. 33 (1989) 1291
43. Setaki D., Tataridis D., Stamatiou G., Kolocouris A., Foscolos G.B., Fytas G., Kolocouris N., Padalko E., Neyts J., and De Clercq E. Bioorg. Chem. 34 (2006) 248
44. Hirumi H., and Hirumi K. J. Parasitol. 75 (1989) 985